课题基金 / 基金详情

COFACTOR REQUIREMENT FOR CD4-MEDIATED HIV-1 ENTRY

COFACTOR REQUIREMENT FOR CD4-MEDIATED HIV-1 ENTRY
CD4 介导的 HIV-1 进入的辅助因子要求
批准号:
2057610
负责人:
Robert D. Harrington
金额:
$8.09万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-09-30 至 1997-08-31

项目摘要

项目成果

Robert D. Harrington的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Research. Expression of the HIV-I receptor CD4 on many non-human and see human cell lines is not sufficient to permit HIV-I infection. The investigator describes human glioblastoma cell line (U373) which remains resistant to HIV-1 despite the added expression of an authentic CD4 molecule. The block to H1V- 1 infection of these cells is strain- independent and appears to be at viral entry. Heterokaryons of CD4- expressing U373 (U373-CD4) cells fused to HeLa cells allow HIV-I entry. A U373-CD4\HeLa hybrid clone allows efficient HIV-I replication. These results suggest that HeLa cells express a factor(s) that can complement the viral entry defect of U373-CD4 cells and which is necessary for efficient HIV-l infection. Experiments that test the ability of additional human cell lines to complement U373-CD4 cells will provide insight into the complexity of the viral entry process. Studies to identify the chromosome encoding the complementing gene and the gene itself will help define the cellular requirements for CD4-mediated HIV-l infection and may provide new targets for interrupting the viral life cycle.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cytotoxic immunoconjugates to deplete persistent HIV reservoirs
  • 批准号:
    10305666
  • 项目类别:
  • 资助金额:
    $70.91万
  • 财政年份:
    2017
  • 负责人:
    Robert D. Harrington
  • 依托单位:
Cytotoxic immunoconjugates to deplete persistent HIV reservoirs
  • 批准号:
    10062853
  • 项目类别:
  • 资助金额:
    $83.47万
  • 财政年份:
    2017
  • 负责人:
    Robert D. Harrington
  • 依托单位:
COFACTOR REQUIREMENT FOR CD4-MEDIATED HIV-1 ENTRY
Clinical Research and Retrovirology (CRRC)
  • 批准号:
    8520674
  • 项目类别:
  • 资助金额:
    $37.05万
  • 财政年份:
    --
  • 负责人:
    Robert D. Harrington
  • 依托单位:
海外基金